Delsole (2876) · FactNo expense recognized in the current period
Recognition of Valuation Losses on Investment Securities
First written in FY2019-Q1. 2 of 6 entries say "Restated". Latest entry: FY2020.
6entries
3years
0from disclosures
How it moved
Same theme, other companies
Recognition of Valuation Losses on Investment Securities and Shares of AffiliatesA theme 211 companies write about · 221 as a headwind · 0 as a tailwind
The whole theme swung hardest in 2017: 8 of 22 companies on the "Worse" side.
56 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 222 threads.Full recordFilings, disclosures and news, newest first
- FY2020No expense recognized in the current periodAnnual report
「Impairment loss on investment securities (△ indicates a gain) 3,858 —」
No impairment loss or gain on investment securities was recognized in the current fiscal year, compared with ¥3.858 million in the previous fiscal year. - FY2020-Q1No expense recognized in the current periodAnnual report
「Impairment loss on investment securities 2,494 —」
No impairment loss on investment securities was recognized in the cumulative first-quarter period, compared with ¥2.494 million in the same period of the previous year. - FY2019RestatedAnnual report
「Impairment loss on investment securities (△ indicates a gain) — 3,858」
The impairment loss on investment securities recognized during the current period amounted to ¥3.858 million, the same as the amount disclosed for the previous cumulative quarter. - FY2019-Q3Increase in amountAnnual report
「Impairment loss on investment securities — 3,858」
The impairment loss on investment securities recognized in the cumulative third-quarter period amounted to ¥3.858 million, an increase from ¥2.494 million in the previous cumulative quarter. - FY2019-Q2RestatedAnnual report
「Impairment loss on investment securities — 2,494」
The Company recognized an impairment loss on investment securities of ¥2.494 million as an extraordinary loss in the cumulative second-quarter period. - FY2019-Q1First statedAnnual report
「Impairment loss on investment securities — 2,494」
The Company recognized an impairment loss on investment securities of ¥2.494 million as an extraordinary loss in the cumulative first-quarter period.